{"url_path":"/sec/gnpx/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1595248/0001437749-26-016755-index.html","accession_number":"0001437749-26-016755","cik":"0001595248","ticker":"GNPX","issuer_name":"Genprex, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1595248/0001437749-26-016755-index.html","primary_entity_key":"0001595248","primary_entity_name":"Genprex, Inc."},"word_count":60,"has_tables":true,"body_markdown":"**Item 5. Other Information**\n\n \n\n*Rule* *10b5-1* *Trading Arrangements and Non-Rule* *10b5-1* *Trading Arrangements*\n\n \n\nDuring the fiscal quarter ended *March 31, 2026*, none of our officers or directors, as those terms are defined in Rule *16a*-*1*(f), adopted or terminated a “Rule *10b5*-*1* trading arrangement” or a “non-Rule *10b5*-*1* trading arrangement,” as those terms are defined in Item *408* of Regulation S-K."}